STAT News

STAT+: Pharmalittle: We’re reading about California insulin sales, a Moderna patent battle, and more

Seven months after the launch of its own low-cost insulin brand, California has distributed more than 120,000 five-pen packs of insulin glargine priced at $55 each

Por STAT News

1 minuto de lectura
Compartir
STAT+: Pharmalittle: We’re reading about California insulin sales, a Moderna patent battle, and more
STAT+: Pharmalittle: We’re reading about California insulin sales, a Moderna patent battle, and more

¿Tiene noticias que compartir con el sector de eventos?

Envíe un comunicado de prensa o una noticia y llegue a miles de profesionales del sector de eventos.

Contáctenos→

Más en Health Tech

Perspectivas relacionadas